Fill Finish Manufacturing Market: Global Industry Analysis and Forecast (2024-2030)

Fill Finish Manufacturing Market Definition:

The final production and the most important phase in the complete pharmaceutical drug manufacturing process are fill-finish. It takes place post upstream bioprocessing and downstream purification. Fill finish manufacturing includes aseptically filling biological medications or medicines in ampoules, vials, bottles, syringes, and cartridges in any form, like sterile liquids, powders, or suspensions.

 

Further, the Fill Finish Manufacturing market is segmented by Product, Application, and geography. On the basis of Product, the Fill Finish Manufacturing market is segmented under Consumables and Instrument. Based on the Application, the Fill Finish Manufacturing market is segmented under Pharmaceutical & Biopharmaceutical Companies, Contract Manufacturing Organizations and other End Users. By geography, the market covers the following Regions: North America, Europe, Asia-Pacific, South America, and Middle East & Africa. For each segment, the market sizing and forecasts have been done on the basis of value (in USD Billion).

 

 

To get more Insights: Request Free Sample Report

 

Fill Finish Manufacturing Market Dynamics:

Market Drivers:

Increased demand for pharmaceutical products: One of the greatest drivers for the Fill Finish Manufacturing Market is the surge in demand for medicinal products. In many circumstances, the same medicine is produced in several dosage forms to meet the needs of different patients. 

The Fill Finish Manufacturing industry is mostly driven by advancements in healthcare. In recent years, the total number of individuals seeking healthcare and medical treatment has increased. This increases pharmaceutical product utilisation, driving the growth of the Fill Finish Manufacturing Market.

 

A greater emphasis on scientific research: Another key driver is the increasing emphasis on scientific research. Governments and private groups have increased their funding for specialized healthcare product research. 

 

Biologics in their purest forms are required for research, and this is an important part of the Fill Finish Manufacturing Market. The increased demand for biologics has created an equal demand for flexible aseptic fill-finish manufacturing techniques. This is driving the Fill Finish Manufacturing Market.

 

The growing use of prefilled syringes for parenteral dose forms: Parenteral dosage form is one of the most common ways used to administer a drug which can give a rapid immune response and assure that pharmaceutical compounds are 100% bioavailable. Prefilled syringes are mostly used to treat chronic ailments that need patients to self-administer drugs, such as cardiovascular disease, diabetes, and immune disorders. 

 

As a result, the rising incidence and occurrence of chronic disorders is a primary driver driving up demand for and usage of prefilled syringes. This increased use and demand results in more production of these prefilled syringes, which indirectly increases the growth of the Fill Finish Manufacturing Market.

 

Market Restraints:

Requirement of the High cost: This fill-finish manufacturing is costly as compared to the other processes. This high cost of isolators or restricted access barrier systems (RABS) is expected to restrain the market’s growth to some extent.

 

Market Trends:

In January 2021, Piramal Pharma Solutions (PPS) announced a collaboration with Thera technologies, a Canadian biopharma company to deliver GMP (good manufacturing practice) manufacturing of sterile fill/finish drug products to assist its first-in-human clinical development services.

 

In January 2020, Alcami Corporation, a leading supplier of fully integrated specially made end-to-end solutions for both the pharmaceutical and biologics sectors, announced the acquisition of TriPharm Services, a newly started state-of-the-art sterile fill-finish manufacturing centre near Research Triangle Park, North Carolina. 

 

TriPharm was acquired after Alcami announced a $17 million upgrade of its sterile fill-finish factory in Charleston, South Carolina.In December 2020, Becton, Dickinson, and Company spent over USD 1.2 billion over four years in its six international production areas in Europe to develop and improve its manufacturing capacity as well as technologies for PFS (pre-fillable syringes) and ADDS (advanced drug delivery systems).

 

Fill Finish Manufacturing Market COVID-19 Insights:

Millions of companies around the world were severely impacted by the COVID-19 pandemic because of lockdowns imposed by the government, which created enormous restrictions on trade and supply chains. The pandemic, on the other hand, has provided various possibilities for pharmaceutical and biopharmaceutical sectors to boost their R&D for coronavirus vaccine formulation.

 

For example, in March 2021, Baxter BioPharma Solutions signed a deal with Moderna for the Fill/Finish Manufacturing of the latter’s COVID-19 vaccine in the United States.

 

Fill Finish Manufacturing Market Segment Analysis:

By Product, the consumables segment dominated the Fill Finish Manufacturing Market with 61% share in 2023. Also, this segment is expected to have a high CAGR during the forecast period.

 

Vials, prefilled syringes, cartridges, and other consumables are all part of the consumables segment. This market’s growth is attributable to a higher replacement rate in comparison with the instruments segment, rising acceptance of prefilled syringes, widespread use of the vials in lyophilization, and increased fill-finish outsourcing. 

 

Because of the disadvantages of the traditional techniques, the usage of prefilled syringes has surged. Prefilled syringes offer various advantages over traditional vial packing, including ease of use. It eliminates the need for the processes required before taking medicine from a vial. Because prefilled syringes have the exact amount, it assists in avoiding dosage issues.

 

As the prevalence of chronic diseases increases, the use and demand for prefilled syringes increase because of their advantages. The ongoing COVID-19 pandemic has also increased the demand for consumables significantly. This results in the growth of the consumables segment of the Fill Finish Manufacturing Market.

 

 

By Application, the contract manufacturing organizations segment dominated the Fill Finish Manufacturing Market with 42% share in 2023.

 

This is because of an increase in fill-finish manufacturing process outsourcing by small-sized biopharmaceutical enterprises and a rise in the number of new entrants into the biologics manufacturing sector.

 

Fill Finish Manufacturing Market Regional Insights:

Europe region dominated the Fill Finish Manufacturing Market with 29.8% share in 2023.

 

The primary factor for Europe’s increase in the market is expected to be the increasing attention of key players on increasing their presence in the area.

 

Other factors such as the introduction of the biosimilar market as a result of the patent expiration of important biologic drugs, as well as the increased prevalence of chronic diseases, are driving the Fill Finish Manufacturing Market in this region.

 

North America region has the second-largest i.e., 24.6% share in 2023.

 

This is because of the existence of a lot of pharmaceutical and biopharmaceutical organizations in this region with considerable production capacity. The increased emphasis on improved biopharmaceutical products, the introduction of the biosimilar industry, and biologic product patent expiration are all contributing to the overall regional market’s growth.

 

Asia Pacific region is expected to have the highest CAGR, 10.1% during the forecast period. This is due to the biopharmaceutical industry’s rapid advancements, as well as the growing patient population. The market will be driven even more by increased government initiatives and a large increase in healthcare R&D infrastructure activities.

 

Fill Finish Manufacturing Market Key Players Insights:

The market is characterized by the existence of a number of well-known firms. These companies control a large portion of the market, have a wide product portfolio, and have a global presence. In addition, the market comprises small to mid-sized competitors that sell a limited variety of items, some of which are self-publishing organizations.

 

The market’s major companies have a significant impact because most of them have extensive global networks through which they can reach their massive client bases. To drive revenue growth and strengthen their positions in the global market, key players in the market, particularly in North America and Europe, are focusing on strategic initiatives such as acquisitions, new collection launches, and partnerships.

 

The objective of the report is to present a comprehensive analysis of the Global Fill Finish Manufacturing market to the stakeholders in the industry. The report provides trends that are most dominant in the Global Fill Finish Manufacturing market and how these trends will influence new business investments and market development throughout the forecast period. The report also aids in the comprehension of the Global Fill Finish Manufacturing Market dynamics and competitive structure of the market by analyzing market leaders, market followers, and regional players.

 

The qualitative and quantitative data provided in the Global Fill Finish Manufacturing market report is to help understand which market segments, regions are expected to grow at higher rates, factors affecting the market, and key opportunity areas, which will drive the industry and market growth through the forecast period. The report also includes the competitive landscape of key players in the industry along with their recent developments in the Global Fill Finish Manufacturing market. The report studies factors such as company size, market share, market growth, revenue, production volume, and profits of the key players in the Global Fill Finish Manufacturing market.

 

 

The report provides Porter’s Five Force Model, which helps in designing the business strategies in the market. The report helps in identifying how many rivals exist, who they are, and how their product quality is in the Global Fill Finish Manufacturing market. The report also analyses if the Global Fill Finish Manufacturing market is easy for a new player to gain a foothold in the market, do they enter or exit the market regularly, if the market is dominated by a few players, etc.

 

The report also includes a PESTEL Analysis, which aids in the development of company strategies. Political variables help in figuring out how much a government can influence the Global Fill Finish Manufacturing market. Economic variables aid in the analysis of economic performance drivers that have an impact on the Global Fill Finish Manufacturing market. Understanding the impact of the surrounding environment and the influence of environmental concerns on the Global Fill Finish Manufacturing market is aided by legal factors.

 

Fill Finish Manufacturing Market Scope:

Fill Finish Manufacturing Market
Market Size in 2023	USD 10.25 Bn.
Market Size in 2030	USD 19.73 Bn.
CAGR (2024-2030)	9.8%
Historic Data	2018-2022
Base Year	2023
Forecast Period	2024-2030
Segment Scope	By Product Consumables Instruments
	By Application Contract Manufacturing Organizations Pharmaceutical and Biotechnology Industries Others
Regional Scope	North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Austria, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America

 

Fill Finish Manufacturing Market Key Players:  

• Becton, Dickson, and Company (US)
• Syntegon Technology GmbH (Germany)
• IMA Industria Macchine Automatiche S.p.A. (Italy)
• Stevanato Group (Italy)
• West Pharmaceutical Services, Inc. (US)
• OPTIMA packaging group GmbH (Germany)
• Bausch Strobel (Germany)
• Groninger & Co.gmbh (Germany)
• Gerresheimer AG (Germany)
• SGD Pharma (France)
• SCHOTT AG (Germany)
• NIPRO (Japan)
• Bausch Advanced Technologies Group (US)